The Medicines Company(美國)

The Medicines Company

TheMedicinesCompanywww.themedicinescompany.com Weareaglobalpharmaceuticalcompanyfocusedonadvancingthetreatmentofcriticalcarepatientsthroughthedeliveryofinnovative,cost-effectivemedicinestotheworldwi dehospitalmarketplace.IntheUnitedStates,wehavethreemarketedproducts,Angiomax®(bivalirudin)forInjection,Cleviprex®(clevidipine)InjectableEmulsion,andArgatrobanInjection,50mgper50mL†.Wealsohaveapipelineofacuteandintensivecarehospitalproductsindevelopment,includingthreelate-stagedevelopmentproductcandidates,cangrelor,oritavancinandMDCO-157,andtwoearlystagedevelopmentproductcandidates,MDCO-2010andMDCO-216.WebelievethatAngiomax,Cleviprexandourproductsindevelopmentpossessfavorableattributesthatcansatisfyunmetmedicalneedsintheacute|intensivecarehospitalproductmarketandoffer,or,inthecaseofourproductsin